{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:57:41Z","timestamp":1790110661642,"version":"4.0.1"},"reference-count":23,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Patients with inflammatory bowel disease (IBD) experience disproportionately high rates of anxiety and depressive symptoms, representing a 2\u20133-fold increased risk versus the general population. While psychological morbidity is well-documented, the relative contributions of disease activity (active vs. inactive), IBD subtype (ulcerative colitis [UC] vs. Crohn\u2019s disease [CD]), and sociodemographic factors remain clinically contested. This study aimed to quantify these relationships to guide targeted interventions. Methods: We conducted a cross-sectional, single-center study comparing 94 consecutive IBD patients (61 UC, 33 CD; mean age 34.2 \u00b1 11.1 years) with 79 age- and sex-matched healthy controls. The psychological status was assessed using the validated Turkish version of the Hospital Anxiety and Depression Scale (HADS), with 14 items (7 per subscale, 0\u201321 range) and established cutoffs (\u226510 for anxiety, \u22657 for depression). Disease activity was objectively classified: UC patients via the Truelove\u2013Witts Index (inactive, mild, moderate, or severe) and CD patients via the Crohn\u2019s Disease Activity Index (CDAI &lt; 150 inactive, \u2265150 active). Statistical analyses employed SPSS 20.0 (IBM Corp., Armonk, NY, USA), including Student\u2019s t-tests, Mann\u2013Whitney U tests, and chi-square tests, with p &lt; 0.05 as the significance threshold. Results: Disease activity was the strongest predictor: active IBD patients exhibited 64% higher anxiety symptom scores (11.2 \u00b1 3.1 vs. 6.8 \u00b1 2.4, p &lt; 0.001) and 107% higher depressive symptom scores (8.9 \u00b1 2.7 vs. 4.3 \u00b1 1.9, p &lt; 0.001) than inactive patients. Gender and education modulated the risk: females showed 23% elevated anxiety (OR 1.23, 95% CI 1.06\u20131.43; p = 0.008), while college education correlated with 31% lower depression odds (OR 0.69, 95% CI 0.51\u20130.93; p = 0.026). Strikingly, 32.1% of IBD patients met depressive symptom thresholds versus 17.7% of controls (p = 0.028). No UC\/CD subtype differences emerged (p &gt; 0.05). Conclusions: Our findings confirm that active IBD inflammation\u2014not the disease subtype (UC\/CD)\u2014is the strongest predictor of anxiety and depressive symptoms, with one in three patients meeting clinical depression thresholds. Women and those with less education face heightened risks, underscoring the need for routine mental health screening during flares and targeted psychosocial support. These results advocate for integrated psychiatric care in IBD management to address this invisible burden.<\/jats:p>","DOI":"10.3390\/jcm14124179","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T06:42:48Z","timestamp":1749710568000},"page":"4179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychological Morbidity in IBD: The Dominant Role of Disease Activity over Subtype and Demographic Factors"],"prefix":"10.3390","volume":"14","author":[{"given":"Sinem","family":"Azizoglu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kocaeli City Hospital, 41060 \u0130zmit, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-1055","authenticated-orcid":false,"given":"Idris","family":"Kurt","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Trakya University School of Medicine, 22130 Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin Ahmet","family":"Tezel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Trakya University School of Medicine, 22130 Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: Useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3999(02)00313-6","article-title":"Impact of major depression on chronic medical illness","volume":"53","author":"Katon","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20873","article-title":"Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management","volume":"15","author":"Graff","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/apt.12335","article-title":"Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: Examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity","volume":"38","author":"Berrill","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9270(01)04037-0","article-title":"Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors","volume":"97","author":"Axelsson","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_7","first-page":"280","article-title":"Hastane anksiyete ve depresyon \u00f6l\u00e7e\u011fi T\u00fcrk\u00e7e formunun ge\u00e7erlilik ve g\u00fcvenilirli\u011fi","volume":"8","author":"Aydemir","year":"1997","journal-title":"T\u00fcrk Psikiyatr. Derg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00054725-200211000-00002","article-title":"The impact of inflammatory bowel disease on labor force participation: Results of a population sampled Case-Control study","volume":"8","author":"Boonen","year":"2002","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","unstructured":"(2024, September 20). NACC Submission to NICE for the Health Technology Appraisal on the Use of Tumour Necrosis Factor Alpha (TNF\u03ac) \u0130nhibitors (Adalimumab, Certolizumab Pegol and \u0130nfliximab [Review]) and Natalizumab for Crohn\u2019s Disease; National Institute for Health and Care Excellence: London, UK, 2007. Available online: https:\/\/www.nice.org.uk\/guidance\/ta187\/documents\/national-association-for-colitis-and-crohns-disease-nacc2."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MPG.0b013e31822f2c32","article-title":"Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease","volume":"53","author":"Ross","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1651-2227.1991.tb11923.x","article-title":"Inflammatory Bowel Disease in Children and Adolescents: A Somatic and Psychiatric Investigation","volume":"80","author":"Lindquist","year":"1991","journal-title":"Acta Paediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jpepsy\/jsp120","article-title":"A Meta-analytic Review of the Psychosocial Adjustment of Youth with Inflammatory Bowel Disease","volume":"35","author":"Greenley","year":"2010","journal-title":"J. Pediatr. Psychol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00004583-198911000-00022","article-title":"Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis","volume":"28","author":"Burke","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106502","DOI":"10.1155\/2012\/106502","article-title":"Psychological Issues in Inflammatory Bowel Disease: An Overview","volume":"2012","author":"Sajadinejad","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1572-0241.2008.01980.x","article-title":"The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders","volume":"103","author":"Walker","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13645","article-title":"Systematic review: Psychological morbidity in young people with inflammatory bowel disease\u2014Risk factors and impacts","volume":"44","author":"Brooks","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.MIB.0000442678.62674.b7","article-title":"Depressive Symptoms in Youth with Inflammatory Bowel Disease Compared with a Community Sample","volume":"20","author":"Lobato","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_18","first-page":"395","article-title":"Depressive Symptoms and Inflammatory bowel Disease in Children and Adolescents: A Cross-Sectional Study","volume":"39","author":"Szigethy","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/ibd.22888","article-title":"Risk factors of anxiety and depression in inflammatory bowel disease","volume":"18","author":"Nahon","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/ajg.2011.142","article-title":"Increased risks of developing anxiety and depression in young patients with Crohn\u2019s disease","volume":"106","author":"Loftus","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.24869\/psyd.2021.48","article-title":"Anxiety, Depression and Personality Types in Patients with Inflammatory Bowel Disease: Comparisons with Peptic Ulcer and the General Population","volume":"33","author":"Babic","year":"2021","journal-title":"Psychiatr. Danub."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/003655202317316097","article-title":"Health-Related Quality of Life and Psychological Distress in a Population-based Sample of Swedish Patients with Inflammatory Bowel Disease","volume":"37","author":"Nordin","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2012-302620","article-title":"Low prevalence of behavioural and emotional problems among Swiss paediatric patients with inflammatory bowel disease","volume":"98","author":"Herzog","year":"2012","journal-title":"Arch. Dis. Child."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:50:43Z","timestamp":1760032243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124179"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124179","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}